The High Toll of US Abortion Bans: Nearly One in Five Patients Now Traveling Out of State for Abortion Care

The High Toll of US Abortion Bans: Nearly One in Five Patients Now Traveling Out of State for Abortion Care

All people deserve access to quality health careincluding abortion servicesin or near their communities. However, fewer and fewer Americans are able to get abortion care in their own state. According to the latest data from the Guttmacher Institutes Monthly Abortion Provision Study, the proportion of patients traveling to other states to obtain abortion care has … Read more

Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor

The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have received at least two lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor, achieved an overall response rate of 72%  INDIANAPOLIS, Dec. 1, … Read more